Kevin Davis Email & Phone Number

New York City Metropolitan Area And New Jersey

Oncology Account Manager (Manhattan, Westchester/Hudson Valley, Brooklyn, Bronx, Queens, Long Island, Connecticut, New Jersey)

New York City Metropolitan Area, New York State, Connecticut

• Achieved 122.0% to goal for Sylvant.• Presently performing at 379 Units QTD.• Enacted sustainable relationships with HCP’s and leveraged customer insights to develop strategic solutions in Ultra Rare Disease Market.

New York City Metropolitan Area, Connecticut

• Leading district with 147.9% with Bavencio. • Formulary achievement in Top 10 Hospital for Bavencio.• Implemented early adoption of Bavencio in Top 5 Accounts.

Bronx, Northern Westchester County, Yonkers

• Leading district with 121.1% with lead product Neulasta OnPro and Vectibix at 140.3%.• Launched first Oncology Therapeutic Biosimilar MVASI. • Drove adoption of Biosimilar MVASI in top accounts. • Formulary achievement for lead product Neulasta OnPro due by first quarter in targeted account.

Greater New York City Area

• Achieved 102% with lead product Jadenu.• Awarded Promacta Top 10 Territory in Country. • Supported drive in early adoption of CAR-T Therapy with Kymriah. • Recognized for Team Collaboration between NJ and NYC.• Selected as Hematology Specialist for Washington DC NMA Convention.

Greater New York City Area

• Ranked Top 10% in performance for Butrans.• Exceeding Territory Performance Attainment at 110% for OxyContin and 110% for Butrans. • Q4 2015 OxyContin prescription performance #51 Nationally out of 530.• Leading the NYC District Q3 2015 with 110 % in Product Class.• Fiscal Year 2014 Ranked 97 out of 525.• 2014 Northeast Region Top Performer in growth for OxyContin and Butrans.• 2014 “All Green Club” exceeded goal for all promoted products.• Awarded for being Top 10 Performer in Northeast Region in 2013. • Butrans launch, “Largest Growth Quarter” contest Q1 2012. • Fiscal Year 2012 Lead Percent to Baseline and 13 vs. 13 growth. • Finished Fiscal Year 2011 in Top 20% within Product Class.• Achieved Exclusive Formulary status for Butrans in Largest Hospital Account. • Ranked Top 10% in Nation 2010 for FFP Total.• Selected as International Representative at 2010 IASP World Congress, Montreal Canada.• Awarded 2009 Toppers Winner, District Representative of the Year and inducted fourth time into Presidents Council.• Ranked Top 10% in Region 2009.• Served as Regional Product Pain Specialist in 2009.• Selected as International Representative for 2008 IASP World Congress, Glasgow Scotland. • Selected as District Field Trainer for The New York District in 2007.• Awarded 2006 Toppers Winner and inducted third time into Presidents Council. • Awarded 2004 Toppers Winner and inducted second time into Presidents Council. • Awarded 2002 Regional Representative of the Year, Toppers Winner, District Representative of the Year, Regional Product Leader of the Year, and inducted first time into Presidents Council. • Awarded 2001 Toppers Winner, District Representative of the Year, and Regional Product Leader of the Year. • Served term as Pain Specialist for North Atlantic Region in 2001.• Completed Leadership Development Program.

Greater New York City Area

• Served as Interim District Manager for the Manhattan District, including planning/facilitating district meetings, and conducting/documenting field sessions with representatives.• Ranked #3 in Manhattan District and #8 in the Northeast Region, with a Product Index of 105.6%.• Achieved exclusive formulary status for Aciphex in second-largest account, one of the first formulary wins for Aciphex in the nation.• Selected as an Advisor for the Initial Product Training Seminar on two occasions.• Completed numerous field-training assignments and in-house training on Risperdal and Duragesic.• Completed the Skills Development Seminar, the Train-the-Trainers Seminar, and the Focused Selection and Interviewing Workshop.• Recognized for alliances with other Johnson & Johnson companies with the Partnership Award.

Greater New York City Area

• Awarded Manhattan District Sales Achievement Award.• Consistent top performer within Manhattan District, achieving a Product Index of 121.69% at time of promotion and ranked #1 in District and #7 in nation.• Featured in Janssen World Magazine.